198 related articles for article (PubMed ID: 22169171)
1. Parity and risk of lung cancer in women: systematic review and meta-analysis of epidemiological studies.
Dahabreh IJ; Trikalinos TA; Paulus JK
Lung Cancer; 2012 May; 76(2):150-8. PubMed ID: 22169171
[TBL] [Abstract][Full Text] [Related]
2. Parity and risk of colorectal cancer: a dose-response meta-analysis of prospective studies.
Guan HB; Wu QJ; Gong TT; Lin B; Wang YL; Liu CX
PLoS One; 2013; 8(9):e75279. PubMed ID: 24098689
[TBL] [Abstract][Full Text] [Related]
3. Parity and pancreatic cancer risk: a dose-response meta-analysis of epidemiologic studies.
Guan HB; Wu L; Wu QJ; Zhu J; Gong T
PLoS One; 2014; 9(3):e92738. PubMed ID: 24658609
[TBL] [Abstract][Full Text] [Related]
4. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
[TBL] [Abstract][Full Text] [Related]
5. Parity and kidney cancer risk: evidence from epidemiologic studies.
Guan HB; Wu QJ; Gong TT
Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2345-53. PubMed ID: 24108791
[TBL] [Abstract][Full Text] [Related]
6. Number of parity and the risk of gallbladder cancer: a systematic review and dose-response meta-analysis of observational studies.
Guo P; Xu C; Zhou Q; Zhou J; Zhao J; Si Z; Shen C; Feng C
Arch Gynecol Obstet; 2016 May; 293(5):1087-96. PubMed ID: 26408005
[TBL] [Abstract][Full Text] [Related]
7. Abdominal Obesity and Lung Cancer Risk: Systematic Review and Meta-Analysis of Prospective Studies.
Hidayat K; Du X; Chen G; Shi M; Shi B
Nutrients; 2016 Dec; 8(12):. PubMed ID: 27983672
[TBL] [Abstract][Full Text] [Related]
8. Maternal parity and the risk of congenital heart defects in offspring: a dose-response meta-analysis of epidemiological observational studies.
Feng Y; Yu D; Chen T; Liu J; Tong X; Yang L; Da M; Shen S; Fan C; Wang S; Mo X
PLoS One; 2014; 9(10):e108944. PubMed ID: 25295723
[TBL] [Abstract][Full Text] [Related]
9. Reproductive factors and lung cancer risk: a comprehensive systematic review and meta-analysis.
Yin X; Zhu Z; Hosgood HD; Lan Q; Seow WJ
BMC Public Health; 2020 Sep; 20(1):1458. PubMed ID: 32977782
[TBL] [Abstract][Full Text] [Related]
10. Residential Radon and Histological Types of Lung Cancer: A Meta-Analysis of Case‒Control Studies.
Li C; Wang C; Yu J; Fan Y; Liu D; Zhou W; Shi T
Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32102460
[TBL] [Abstract][Full Text] [Related]
11. Parity and endometrial cancer risk: a meta-analysis of epidemiological studies.
Wu QJ; Li YY; Tu C; Zhu J; Qian KQ; Feng TB; Li C; Wu L; Ma XX
Sci Rep; 2015 Sep; 5():14243. PubMed ID: 26373341
[TBL] [Abstract][Full Text] [Related]
12. Parity and bladder cancer risk: a dose-response meta-analysis.
Bai Y; Wang X; Yang Y; Tang Y; Wang J; Han P
BMC Cancer; 2017 Jan; 17(1):31. PubMed ID: 28061845
[TBL] [Abstract][Full Text] [Related]
13. Parity and pancreatic cancer risk: evidence from a meta-analysis of twenty epidemiologic studies.
Zhu B; Zou L; Han J; Chen W; Shen N; Zhong R; Li J; Chen X; Liu C; Shi Y; Miao X
Sci Rep; 2014 Jun; 4():5313. PubMed ID: 24936955
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus as an independent risk factor for lung cancer: a meta-analysis of observational studies.
Lee JY; Jeon I; Lee JM; Yoon JM; Park SM
Eur J Cancer; 2013 Jul; 49(10):2411-23. PubMed ID: 23562551
[TBL] [Abstract][Full Text] [Related]
15. MECHANISMS IN ENDOCRINOLOGY: Parity and risk of type 2 diabetes: a systematic review and dose-response meta-analysis.
Li P; Shan Z; Zhou L; Xie M; Bao W; Zhang Y; Rong Y; Yang W; Liu L
Eur J Endocrinol; 2016 Nov; 175(5):R231-45. PubMed ID: 27334332
[TBL] [Abstract][Full Text] [Related]
16. Parity and Cardiovascular Disease Mortality: a Dose-Response Meta-Analysis of Cohort Studies.
Lv H; Wu H; Yin J; Qian J; Ge J
Sci Rep; 2015 Aug; 5():13411. PubMed ID: 26299306
[TBL] [Abstract][Full Text] [Related]
17. Flavonoids intake and risk of lung cancer: a meta-analysis.
Tang NP; Zhou B; Wang B; Yu RB; Ma J
Jpn J Clin Oncol; 2009 Jun; 39(6):352-9. PubMed ID: 19351659
[TBL] [Abstract][Full Text] [Related]
18. Tea consumption and lung cancer risk: a meta-analysis of case-control and cohort studies.
Wang L; Zhang X; Liu J; Shen L; Li Z
Nutrition; 2014 Oct; 30(10):1122-7. PubMed ID: 25194612
[TBL] [Abstract][Full Text] [Related]
19. Asthma and lung cancer risk: a systematic investigation by the International Lung Cancer Consortium.
Rosenberger A; Bickeböller H; McCormack V; Brenner DR; Duell EJ; Tjønneland A; Friis S; Muscat JE; Yang P; Wichmann HE; Heinrich J; Szeszenia-Dabrowska N; Lissowska J; Zaridze D; Rudnai P; Fabianova E; Janout V; Bencko V; Brennan P; Mates D; Schwartz AG; Cote ML; Zhang ZF; Morgenstern H; Oh SS; Field JK; Raji O; McLaughlin JR; Wiencke J; LeMarchand L; Neri M; Bonassi S; Andrew AS; Lan Q; Hu W; Orlow I; Park BJ; Boffetta P; Hung RJ
Carcinogenesis; 2012 Mar; 33(3):587-97. PubMed ID: 22198214
[TBL] [Abstract][Full Text] [Related]
20. Obesity and incidence of lung cancer: a meta-analysis.
Yang Y; Dong J; Sun K; Zhao L; Zhao F; Wang L; Jiao Y
Int J Cancer; 2013 Mar; 132(5):1162-9. PubMed ID: 22777722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
